IBDEI0WW ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16244,1,4,0)
 ;;=4^354.2
 ;;^UTILITY(U,$J,358.3,16244,1,5,0)
 ;;=5^Ulnar Nerve Entrapment
 ;;^UTILITY(U,$J,358.3,16244,2)
 ;;=^268506
 ;;^UTILITY(U,$J,358.3,16245,0)
 ;;=729.1^^92^935^35
 ;;^UTILITY(U,$J,358.3,16245,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16245,1,4,0)
 ;;=4^729.1
 ;;^UTILITY(U,$J,358.3,16245,1,5,0)
 ;;=5^Fibromyalgia
 ;;^UTILITY(U,$J,358.3,16245,2)
 ;;=Fibromyalgia^80160
 ;;^UTILITY(U,$J,358.3,16246,0)
 ;;=438.20^^92^935^11
 ;;^UTILITY(U,$J,358.3,16246,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16246,1,4,0)
 ;;=4^438.20
 ;;^UTILITY(U,$J,358.3,16246,1,5,0)
 ;;=5^CVA w/Hemiplegia (late effect)
 ;;^UTILITY(U,$J,358.3,16246,2)
 ;;=CVA w/Hemiplegia^317910
 ;;^UTILITY(U,$J,358.3,16247,0)
 ;;=438.12^^92^935^8
 ;;^UTILITY(U,$J,358.3,16247,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16247,1,4,0)
 ;;=4^438.12
 ;;^UTILITY(U,$J,358.3,16247,1,5,0)
 ;;=5^CVA w/Dysphasia (late effect)
 ;;^UTILITY(U,$J,358.3,16247,2)
 ;;=Stroke w/Dysphasia^317908
 ;;^UTILITY(U,$J,358.3,16248,0)
 ;;=356.8^^92^935^90
 ;;^UTILITY(U,$J,358.3,16248,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16248,1,4,0)
 ;;=4^356.8
 ;;^UTILITY(U,$J,358.3,16248,1,5,0)
 ;;=5^Peripheral Neuropathy, Idiopathic
 ;;^UTILITY(U,$J,358.3,16248,2)
 ;;=Peripheral Neuropathy, Idio^268525
 ;;^UTILITY(U,$J,358.3,16249,0)
 ;;=337.20^^92^935^100
 ;;^UTILITY(U,$J,358.3,16249,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16249,1,4,0)
 ;;=4^337.20
 ;;^UTILITY(U,$J,358.3,16249,1,5,0)
 ;;=5^Reflexive Sympathetic Dystrophy
 ;;^UTILITY(U,$J,358.3,16249,2)
 ;;=Reflexive Sympathetic Dystrophy^295799
 ;;^UTILITY(U,$J,358.3,16250,0)
 ;;=294.8^^92^935^33
 ;;^UTILITY(U,$J,358.3,16250,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16250,1,4,0)
 ;;=4^294.8
 ;;^UTILITY(U,$J,358.3,16250,1,5,0)
 ;;=5^Dementia, Other
 ;;^UTILITY(U,$J,358.3,16250,2)
 ;;=^268044
 ;;^UTILITY(U,$J,358.3,16251,0)
 ;;=438.6^^92^935^7
 ;;^UTILITY(U,$J,358.3,16251,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16251,1,4,0)
 ;;=4^438.6
 ;;^UTILITY(U,$J,358.3,16251,1,5,0)
 ;;=5^CVA w/Dysesthesia (late effect)
 ;;^UTILITY(U,$J,358.3,16251,2)
 ;;=CVA w/Dysesthesia (late effect)^328503
 ;;^UTILITY(U,$J,358.3,16252,0)
 ;;=438.7^^92^935^26
 ;;^UTILITY(U,$J,358.3,16252,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16252,1,4,0)
 ;;=4^438.7
 ;;^UTILITY(U,$J,358.3,16252,1,5,0)
 ;;=5^CVA w/Vision Changes (late effect)
 ;;^UTILITY(U,$J,358.3,16252,2)
 ;;=CVA w/Vision Changes (late effect)^328504
 ;;^UTILITY(U,$J,358.3,16253,0)
 ;;=438.84^^92^935^5
 ;;^UTILITY(U,$J,358.3,16253,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16253,1,4,0)
 ;;=4^438.84
 ;;^UTILITY(U,$J,358.3,16253,1,5,0)
 ;;=5^CVA w/Ataxia (late effect)
 ;;^UTILITY(U,$J,358.3,16253,2)
 ;;=CVA w/Ataxia (late effect)^328507
 ;;^UTILITY(U,$J,358.3,16254,0)
 ;;=434.91^^92^935^27
 ;;^UTILITY(U,$J,358.3,16254,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16254,1,4,0)
 ;;=4^434.91
 ;;^UTILITY(U,$J,358.3,16254,1,5,0)
 ;;=5^CVA, Acute Onset
 ;;^UTILITY(U,$J,358.3,16254,2)
 ;;=^295738
 ;;^UTILITY(U,$J,358.3,16255,0)
 ;;=333.94^^92^935^101
 ;;^UTILITY(U,$J,358.3,16255,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16255,1,4,0)
 ;;=4^333.94
 ;;^UTILITY(U,$J,358.3,16255,1,5,0)
 ;;=5^Restless Leg Syndrome
 ;;^UTILITY(U,$J,358.3,16255,2)
 ;;=^105368
 ;;^UTILITY(U,$J,358.3,16256,0)
 ;;=345.90^^92^935^104
 ;;^UTILITY(U,$J,358.3,16256,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16256,1,4,0)
 ;;=4^345.90
 ;;^UTILITY(U,$J,358.3,16256,1,5,0)
 ;;=5^Seizure Disorder
 ;;^UTILITY(U,$J,358.3,16256,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,16257,0)
 ;;=907.0^^92^935^73
